InsiderClue
← All stocks

ROCKET PHARMACEUTICALS, INC.

RCKT Net selling
CIK 0001281895 #3320 in the set updated 17 Sep 2026
Bought (12 mo)
$34.40K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$978.59K
$0.00 on a plan · $171.84K straight out of an exercise
Sold at will
$806.74K
28 of 29 sales
Net
−$944.19K
−$772.34K against sales at will

By person

21 insiders · 33 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Wilson Martin
General Counsel
—
$334.61K (8)
−$334.61K
598,489
0.5452%
$2.04M
+824.5%
Shah Gaurav
CEO
—
$285.67K (8) scheduled
−$285.67K
1,056,594
0.9625%
$3.60M
+47.1%
Militello John
See Remarks
—
$138.26K (9)
−$138.26K
89,780
0.0818%
$305.52K
+74.5%
Stevens Christopher James
Chief Operating Officer
—
$128.27K (1)
−$128.27K
505,784
0.4607%
$1.72M
—
Chaudhuri Sarbani
See Remarks
—
$84.19K (2)
−$84.19K
262,809
0.2394%
$894.34K
+65.0%
Bjork Elisabeth
Director
$34.40K (1)
—
+$34.40K
50,000
0.0455%
$170.15K
—
Schwartz Jonathan David
See Remarks
—
$7.59K (1)
−$7.59K
299,064
0.2724%
$1.02M
+79.1%
RTW INVESTMENTS, LP entity
Director
—
—
—
18,188,457
16.57%
$61.90M
0.0%
Patel Kinnari
See Remarks
—
—
—
468,701
0.4270%
$1.59M
+16.4%
Makker Gotham
Director
—
—
—
415,346
0.3784%
$1.41M
+13.5%
Rizvi Syed Ali-aamir
Chief Medical Officer
—
—
—
407,874
0.3716%
$1.39M
—
SOUTHWELL DAVID P
Director
—
—
—
204,522
0.1863%
$695.99K
+12,221%
Ondrey Aaron
Chief Financial Officer
—
—
—
128,173
0.1168%
$436.17K
+174.0%
Fong Peter
Director
—
—
—
76,195
0.0694%
$259.29K
—
WONG RODERICK
Director
—
—
—
75,499
0.0688%
$256.92K
—
White Mark Andrew
See Remarks
—
—
—
69,140
0.0630%
$235.28K
−4.3%
Dolsten Mikael
Director
—
—
—
67,082
0.0611%
$228.28K
—
GRANADILLO PEDRO P
Director
—
—
—
54,734
0.0499%
$186.26K
—
Malik Fady Ibraham
Director
—
—
—
52,862
0.0482%
$179.89K
—
BOESS CARSTEN
Director
—
—
—
52,862
0.0482%
$179.89K
—
Pratumsuwan Piratip
Director
—
—
—
30,000
0.0273%
$102.09K
—

Individual transactions

33
Insider
Date
Role
Action
Shares
Price
Amount
Wilson Martin
11 Sep 2026
General Counsel
Sell
75,364
$3.40
$256.46K
Shah Gaurav
18 Aug 2026
CEO
Sell
2,293
$3.38
$7.75K
Wilson Martin
18 Aug 2026
General Counsel
Sell
631
$3.38
$2.13K
Wilson Martin
13 Aug 2026
General Counsel
Sell
3,493
$3.38
$11.81K
Shah Gaurav
13 Aug 2026
CEO
Sell
2,837
$3.38
$9.59K
Chaudhuri Sarbani
11 Aug 2026
See Remarks
Sell
4,701
$3.50
$16.45K
Stevens Christopher James
11 Aug 2026
Chief Operating Officer
Sell
36,658
$3.50
$128.27K
Shah Gaurav
21 May 2026
CEO
Sold after exercise
55,684
$3.09
$171.84K
Militello John
19 May 2026
See Remarks
Sell
384
$3.01
$1.16K
Wilson Martin
19 May 2026
General Counsel
Sell
662
$3.01
$2.00K
Shah Gaurav
19 May 2026
CEO
Sell
2,409
$3.01
$7.26K
Militello John
13 May 2026
See Remarks
Sell
855
$3.61
$3.08K
Shah Gaurav
13 May 2026
CEO
Sell
2,728
$3.61
$9.84K
Wilson Martin
13 May 2026
General Counsel
Sell
3,361
$3.61
$12.12K
Chaudhuri Sarbani
7 May 2026
See Remarks
Sell
17,650
$3.84
$67.74K
Wilson Martin
18 Feb 2026
General Counsel
Sell
1,376
$3.34
$4.59K
Shah Gaurav
18 Feb 2026
CEO
Sell
5,990
$3.34
$19.99K
Militello John
18 Feb 2026
See Remarks
Sell
1,157
$3.34
$3.86K
Shah Gaurav
13 Feb 2026
CEO
Sell
12,279
$3.31
$40.67K
Militello John
13 Feb 2026
See Remarks
Sell
3,726
$3.31
$12.34K
Wilson Martin
13 Feb 2026
General Counsel
Sell
12,253
$3.31
$40.58K
Bjork Elisabeth
2 Jan 2026
Director
Buy
10,000
$3.44
$34.40K
Wilson Martin
18 Nov 2025
General Counsel
Sell
1,646
$2.98
$4.91K
Shah Gaurav
18 Nov 2025
CEO
Sell
6,276
$2.98
$18.72K
Militello John
18 Nov 2025
See Remarks
Sell
1,086
$2.98
$3.24K
Schwartz Jonathan David
18 Nov 2025
See Remarks
Sell
2,545
$2.98
$7.59K
Militello John
14 Oct 2025
See Remarks
Sell
558
$3.98
$2.22K
Militello John
14 Oct 2025
See Remarks
Sell
3,005
$3.97
$11.93K
Militello John
14 Oct 2025
See Remarks
Sell
5,514
$3.97
$21.86K
Militello John
14 Oct 2025
See Remarks
Sell
19,841
$3.96
$78.57K
RTW INVESTMENTS, LP
19 Sep 2025
Director
Exercised, kept indirect
59,000
$17.81
$1.05M
RTW INVESTMENTS, LP
19 Sep 2025
Director
Exercised, kept indirect
41,000
$19.09
$782.76K
RTW INVESTMENTS, LP
19 Sep 2025
Director
Exercised, kept indirect
1,000,000
$40.03
$40.03M

What was left out

Form 4 filings counted 46
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 28
Transactions with no price 0
Shares from compensation/vesting 4,018,862
History held since 29 Sep 2016